Varicella-zoster virus infection under administration of ganciclovir after allogeneic bone marrow transplantation.
Mori
Takehiko
T
Division of Hematology, Department of Medicine, Keio University School of Medicine, Shinanomachi, Tokyo, Japan. tmori@sc.itc.keio.ac.jp
Shimizu
Takayuki
T
Yamazaki
Rie
R
Aisa
Yoshinobu
Y
Nakazato
Tomonori
T
Ikeda
Yauso
Y
Okamoto
Shinichiro
S
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D005260:Female; D015774:Ganciclovir / Q000008:administration & dosage* / Q000627:therapeutic use; D006562:Herpes Zoster / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control* / Q000821:virology; D014645:Herpesvirus 3, Human / Q000502:physiology*; D006801:Humans; D014184:Transplantation, Homologous / Q000009:adverse effects*; D014775:Virus Activation
D000998:Antiviral Agents; D015774:Ganciclovir